3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.77%
Negative revenue growth while IXX.DE stands at 22.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-22.70%
Negative gross profit growth while IXX.DE is at 20.63%. Joel Greenblatt would examine cost competitiveness or demand decline.
-59.22%
Negative EBIT growth while IXX.DE is at 152.61%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-58.79%
Negative operating income growth while IXX.DE is at 108.57%. Joel Greenblatt would press for urgent turnaround measures.
-62.10%
Negative net income growth while IXX.DE stands at 220.62%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-62.07%
Negative EPS growth while IXX.DE is at 228.57%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-62.07%
Negative diluted EPS growth while IXX.DE is at 228.57%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.81%
Dividend reduction while IXX.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
197.33%
Positive OCF growth while IXX.DE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
287.89%
Positive FCF growth while IXX.DE is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.73%
3Y revenue/share CAGR at 75-90% of IXX.DE's 11.27%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-81.49%
Negative 3Y CAGR while IXX.DE is 67.43%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.09%
3Y equity/share CAGR above 1.5x IXX.DE's 11.48%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-83.30%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-17.68%
Firm’s AR is declining while IXX.DE shows 25.28%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.26%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.30%
Negative asset growth while IXX.DE invests at 5.23%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.91%
75-90% of IXX.DE's 3.46%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-6.83%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-5.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.